XML 220 R31.htm IDEA: XBRL DOCUMENT v3.25.2
Acquisition (Tables)
12 Months Ended
Jun. 30, 2025
Acquisition  
Summary of preliminary allocation of purchase price to fair values assigned to assets acquired and liabilities assumed

Initial

Measurement

Updated

    

Purchase Price Allocation

Period Changes

Purchase Price Allocation

Assets acquired:

Cash and cash equivalents

$

11,018

$

-

$

11,018

Accounts receivable, net

350

-

350

Inventories, net

149,316

(10,335)

138,981

Property, plant and equipment

139,603

5,361

144,964

Other assets (1)

24,048

(10,840)

13,208

Goodwill (2)

-

4,948

4,948

Total fair value of assets acquired

324,335

(10,866)

313,469

Liabilities assumed:

Accounts payable

1,411

-

1,411

Accrued expenses and other current liabilities

14,395

(10,230)

4,165

Other noncurrent liabilities

6,686

3,660

10,346

Total fair value of liabilities assumed

22,492

(6,570)

15,922

Fair value of net assets acquired

$

301,843

$

(4,296)

$

297,547

(1)Includes current and noncurrent amounts.
(2)Goodwill is reported within the Animal Health segment. Based on our preliminary assessment, an immaterial amount of the goodwill is currently expected to be deductible for tax purposes. Our assessment of the tax considerations regarding the Acquisition is not yet final and may be subject to change.

 

Schedule of pro forma results

Three Months

Twelve Months

For the Periods Ended June 30,

    

2025

    

2024

    

2025

    

2024

Net sales

$

378,697

$

359,921

$

1,446,572

$

1,402,984

Operating income

33,718

46,082

153,863

125,303